| |
 |
|
Class Information
Number: 514/741
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Nitrogen containing compound doai > Benzene ring containing
Description: Subject matter wherein the compound contains a benzene ring.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7622508 |
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
Nov. 24, 2009 |
| 7618966 |
Abnormal Cannabidiols as agents for lowering intraocular pressure |
Nov. 17, 2009 |
| 7572798 |
Combi-molecules having signal transduction inhibitory properties and DNA damaging properties |
Aug. 11, 2009 |
| 7566740 |
Method of treating mucositis |
Jul. 28, 2009 |
| 7560098 |
Compounds derived from polyanhydride resins with film-forming, UV-absorbing, and photostabilizing properties, compositions containing same, and methods of using the same |
Jul. 14, 2009 |
| 7550134 |
Compounds derived from polyanhydride resins with film-forming, UV-absorbing, and photostabilizing properties, compositions containing same, and methods of using the same |
Jun. 23, 2009 |
| 7514470 |
Aniline derivatives as selective androgen receptor modulators |
Apr. 7, 2009 |
| 7432307 |
Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation |
Oct. 7, 2008 |
| 7432289 |
5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
Oct. 7, 2008 |
| 7407648 |
Merocyanine derivatives for cosmetic use |
Aug. 5, 2008 |
| 7378409 |
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
May. 27, 2008 |
| 7358226 |
Ultrasonic concentration of drug delivery capsules |
Apr. 15, 2008 |
| 7316738 |
Milled submicron chlorothalonil with narrow particle size distribution, and uses thereof |
Jan. 8, 2008 |
| 7268161 |
Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
Sep. 11, 2007 |
| 7241741 |
Methods and compositions for the treatment of asthma and related disorders |
Jul. 10, 2007 |
| 7232847 |
4-hydroxymethyl-1-aryl-cyclohexylamine compounds |
Jun. 19, 2007 |
| 7041704 |
Methods of treating gastrointestinal tract disorders using sodium channel modulators |
May. 9, 2006 |
| 7012100 |
Cell migration inhibiting compositions and methods and compositions for treating cancer |
Mar. 14, 2006 |
| 6878750 |
Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
Apr. 12, 2005 |
| 6759437 |
Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
Jul. 6, 2004 |
| 6730686 |
Methods for inhibiting oxidative modification of proteins |
May. 4, 2004 |
| 6656960 |
Methods of performing vagal-induced asystole |
Dec. 2, 2003 |
| 6653353 |
Cosmetic and personal care compositions |
Nov. 25, 2003 |
| 6642243 |
Migraine medicine and method for treating same |
Nov. 4, 2003 |
| 6627177 |
Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof |
Sep. 30, 2003 |
| 6503953 |
Methods for treating atopic disorders |
Jan. 7, 2003 |
| 6498191 |
Mitochondria protecting agents for treating mitochondria associated diseases |
Dec. 24, 2002 |
| 6495607 |
Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
Dec. 17, 2002 |
| 6495567 |
Triaryl methane compounds and their use in the treatment of diarrhea and scours |
Dec. 17, 2002 |
| 6486209 |
Use for 1,3-propanediol derivatives |
Nov. 26, 2002 |
| 6472411 |
Advanced glycation end-product intermediaries and post-amadori inhibition |
Oct. 29, 2002 |
| 6462091 |
Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications |
Oct. 8, 2002 |
| 6458850 |
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
Oct. 1, 2002 |
| 6458851 |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
Oct. 1, 2002 |
| 6444699 |
Method for treatment of aging or damage skin |
Sep. 3, 2002 |
| 6433011 |
Method for inhibiting formation of aberrant crypt foci in the colon of a mammal |
Aug. 13, 2002 |
| 6433023 |
Compositions having anti-leishmanial activity |
Aug. 13, 2002 |
| 6429217 |
Pharmacological drug combination in vagal-induced asystole |
Aug. 6, 2002 |
| 6414033 |
Drug dosage form based on the teorell-meyer gradient |
Jul. 2, 2002 |
| 6403657 |
Comprehensive pharmacologic therapy for treatment of obesity |
Jun. 11, 2002 |
| 6384031 |
Cyclobutene derivatives useful as antagonists of the motilin receptor |
May. 7, 2002 |
| 6344358 |
Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
Feb. 5, 2002 |
| 6342499 |
Parasitic and saprophagous mite control in beneficial insects |
Jan. 29, 2002 |
| 6329428 |
Therapeutic drug for the treatment of micturition disorders |
Dec. 11, 2001 |
| 6323243 |
Tyrosine-derived compounds as calcium channel antagonists |
Nov. 27, 2001 |
| 6310103 |
S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
Oct. 30, 2001 |
| 6287601 |
Topical nitric oxide donor compositions |
Sep. 11, 2001 |
| 6274629 |
Use for 1,3-propanediol derivatives |
Aug. 14, 2001 |
| 6271264 |
Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants |
Aug. 7, 2001 |
| 6255350 |
Stabilized concentrates of water unstable AZA compounds and o/w miniemulsions thereof |
Jul. 3, 2001 |
|
|
|
